糖尿病前期市場按治療/管理、性別、年齡層、分銷管道、體重類別、最終用戶和地區分類

2025 年糖尿病前期市場規模估計為 88.1 億美元，預計 2032 年將達到 151 億美元，2025 年至 2032 年的複合年成長率為 8.1%。

全球糖尿病前期市場是更廣泛的糖尿病管理生態系統中一個關鍵的細分市場，致力於解決第二型糖尿病發病前普遍存在的葡萄糖耐受不良和血糖值。糖尿病前期的特徵是血糖值高於正常水平，但未達到糖尿病閾值，影響全球數百萬人，是預防糖尿病發展的關鍵干預窗口。

這個市場包括專為糖尿病前期設計的診斷工具、治療性介入、監測設備和生活方式管理解決方案。肥胖率上升、久坐不動的生活方式和人口老化導致糖尿病前期發病率上升，促使全球醫療保健系統優先考慮早期發現和干涉策略。這個市場的重要性不僅限於眼前的醫療保健需求，還在於透過預防性照護方法實現長期成本節約。主要相關人員包括開發降血糖藥物的製藥公司、開發連續血糖監測系統的醫療設備製造商、提供篩檢測試的篩檢實驗室以及提供生活方式干涉計劃的數位健康平台。糖尿病前期市場的發展反映了醫療保健產業向預防性護理的模式轉移，強調早期療育以減少糖尿病相關併發症和醫療保健支出，同時透過及時識別和管理血糖代謝異常來改善患者的預後。

市場動態

全球糖尿病前期市場正經歷強勁成長，這得益於推動市場擴張和技術創新的若干相互關聯的因素。關鍵促進因素包括全球糖尿病前期盛行率的上升，估計全球有3.74億成年人患有葡萄糖耐受不良，這帶來了對診斷和治療解決方案的巨大需求。此外，非侵入性血糖監測設備和數位健康平台的技術進步正在增強患者參與度和監測能力。然而，該市場也面臨許多限制因素，包括新興市場醫療基礎設施有限、持續血糖監測系統高成本，以及許多醫療體系對糖尿病前期管理計畫的報銷不足。

此外，患者對生活方式改變和藥物依從性的挑戰仍然是市場滲透的持續障礙。儘管有這些限制，但透過開發利用基因檢測和生物標記識別的個人化醫療方法，糖尿病前期的個人化介入正在湧現出巨大的機會。人工智慧和機器學習與糖尿病風險評估預測分析的整合正在開闢新的市場管道，而遠距遠端醫療能力和遠端患者監護解決方案的擴展正在解決就醫的地理障礙。此外，製藥公司越來越注重開發針對糖尿病前期的新型療法，加上強調預防性醫療保健的企業健康計劃的擴展，正在為整個糖尿病前期管理領域的相關人員創造更多市場機會。

本次調查的主要特點

• 本報告對全球糖尿病前期市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並說明了針對該市場的引人注目的投資提案。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數概述了全球糖尿病前期市場的主要企業。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
• 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員將透過用於分析全球糖尿病前期市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章：調查目標和先決條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 抑制因素
• 機會
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 產業趨勢

4. 2020 年至 2032 年全球糖尿病前期市場（依治療及管理）

• Metformin
• 數位健康和穿戴設備
• 血糖值監測設備（CGM、BGM）
• 草藥補充劑
• 其他（益生菌、腸道環境改善產品等）

5. 2020-2032 年全球糖尿病前期市場（依性別）

• 男性
• 女士

6. 2020 年至 2032 年按年齡分類的全球糖尿病前期市場

• 成人
• 孩子們

7. 2020-2032 年全球糖尿病前期市場（依通路分類）

• 線上
• 離線

8. 2020 年至 2032 年按體重類別分類的全球糖尿病前期市場

• 超重和肥胖人群（主要目標群）
• 體重正常但有代謝風險的個體（未確診族群）

9. 2020 年至 2032 年全球糖尿病前期市場（依最終使用者分類）

• 醫院
• 診斷實驗室
• 居家照護環境
• 專科診所
• 健康與健康中心

10. 2020 年至 2032 年全球糖尿病前期市場（按地區）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第11章競爭格局

• Bristol-Myers Squibb
• Mylan Pharmaceuticals
• Teva Pharmaceuticals
• Sun Pharmaceutical Industries
• Sandoz（Novartis）
• Glenmark
• Dexcom
• Abbott Laboratories
• Medtronic
• Ascensia Diabetes Care
• Senseonics
• Herbalife Nutrition
• Nestle Health Science
• Danone

第 12 章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第13章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Prediabetes Market is estimated to be valued at USD 8.81 Bn in 2025 and is expected to reach USD 15.10 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

The global prediabetes market represents a critical segment within the broader diabetes management ecosystem, addressing the growing prevalence of impaired glucose tolerance and elevated blood sugar levels that precede type 2 diabetes onset. Prediabetes, characterized by blood glucose levels higher than normal but not yet reaching diabetic thresholds, affects millions worldwide and serves as a crucial intervention window for preventing progression to full-blown diabetes.

The market encompasses diagnostic tools, therapeutic interventions, monitoring devices, and lifestyle management solutions specifically designed for prediabetic populations. With rising obesity rates, sedentary lifestyles, and aging demographics contributing to increased prediabetes prevalence, healthcare systems globally are prioritizing early detection and intervention strategies. The market's significance extends beyond immediate healthcare needs, encompassing long-term cost reduction through preventive care approaches. Key stakeholders include pharmaceutical companies developing glucose-lowering medications, medical device manufacturers creating continuous glucose monitoring systems, diagnostic laboratories offering screening tests, and digital health platforms providing lifestyle intervention programs. The prediabetes market's evolution reflects the healthcare industry's paradigm shift toward preventive medicine, emphasizing early intervention to reduce diabetes-related complications and healthcare expenditures while improving patient outcomes through timely identification and management of glucose metabolism disorders.

Market Dynamics

The global prediabetes market experiences robust growth, driven by several interconnected factors that collectively propel market expansion and innovation. Primary drivers include the escalating global prevalence of prediabetes, with an estimated 374 million adults worldwide living with impaired glucose tolerance, creating substantial demand for diagnostic and therapeutic solutions. Increasing healthcare awareness campaigns and government initiatives promoting early diabetes screening contribute significantly to market growth, as do technological advancements in non-invasive glucose monitoring devices and digital health platforms that enhance patient engagement and monitoring capabilities. However, the market faces notable restraints including limited healthcare infrastructure in developing regions, high costs associated with continuous glucose monitoring systems, and insufficient reimbursement coverage for prediabetes management programs in many healthcare systems.

Additionally, patient compliance challenges with lifestyle modifications and medication adherence present ongoing obstacles to market penetration. Despite these constraints, substantial opportunities emerge through the development of personalized medicine approaches utilizing genetic testing and biomarker identification for tailored prediabetes interventions. The integration of artificial intelligence and machine learning in predictive analytics for diabetes risk assessment opens new market avenues, while expanding telemedicine capabilities and remote patient monitoring solutions address geographical barriers to care access. Furthermore, pharmaceutical companies' increasing focus on developing novel therapeutic agents specifically targeting prediabetic populations, combined with growing corporate wellness programs emphasizing preventive healthcare, creates additional market opportunities for stakeholders across the prediabetes management spectrum.

Key Features of the Study

• This report provides an in-depth analysis of the global prediabetes market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global prediabetes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bristol-Myers Squibb, Mylan Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Sandoz (Novartis), Glenmark, Dexcom, Abbott Laboratories, Medtronic, Ascensia Diabetes Care, Senseonics, Herbalife Nutrition, Nestle Health Science, and Danone
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global prediabetes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prediabetes market

Market Segmentation

• Treatment & Management Insights (Revenue, USD Bn, 2020 - 2032)
  • Metformin
  • Digital Health and Wearables
  • Glucose Monitoring Devices (CGM, BGM)
  • Herbal Supplements
  • Others (Probiotics and Gut Health Products, etc.)
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adult
  • Pediatric
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Online
  • Offline
  • Specialty Pharmacies and Drugstores
  • Supermarkets or Hypermarkets
• Weight Category Insights (Revenue, USD Bn, 2020 - 2032)
  • Overweight and Obese Individuals (Primary Target)
  • Normal Weight with Metabolic Risk (Underdiagnosed Segment)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Specialty Clinics
  • Health and Wellness Centers
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Bristol-Myers Squibb
  • Mylan Pharmaceuticals
  • Teva Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Sandoz (Novartis)
  • Glenmark
  • Dexcom
  • Abbott Laboratories
  • Medtronic
  • Ascensia Diabetes Care
  • Senseonics
  • Herbalife Nutrition
  • Nestle Health Science
  • Danone

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Prediabetes Market, By Treatment & Management
  • Global Prediabetes Market, By Gender
  • Global Prediabetes Market, By Age Group
  • Global Prediabetes Market, By Distribution Channel
  • Global Prediabetes Market, By Weight Category
  • Global Prediabetes Market, By End User
  • Global Prediabetes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Prediabetes Market, By Treatment & Management, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Metformin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Digital Health and Wearables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Glucose Monitoring Devices (CGM, BGM)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Herbal Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Probiotics and Gut Health Products, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Prediabetes Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Prediabetes Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Prediabetes Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Offline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Specialty Pharmacies and Drugstores
    • Supermarkets or Hypermarkets

8. Global Prediabetes Market, By Weight Category, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Overweight and Obese Individuals (Primary Target)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Normal Weight with Metabolic Risk (Underdiagnosed Segment)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Prediabetes Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Health and Wellness Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Prediabetes Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Bristol-Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mylan Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sun Pharmaceutical Industries
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sandoz (Novartis)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Glenmark
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dexcom
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ascensia Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Senseonics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Herbalife Nutrition
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nestle Health Science
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danone
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us